MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Environmental toxicants and Parkinson’s disease in south of Morocco

Y. Naji, N. Kissani (Marrakech, Morocco)

Meeting: 2019 International Congress

Abstract Number: 1518

Keywords: Environmental toxins, Heavy metals, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Environmental Causes

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: Focus on epidemiologic data for environmental agents as potential risk factors throw our experience in third level hospital of Marrakesh Morocco.

Background: This multidisciplinary study brings clinicians, biologists and biochemists together in order to clearly demonstrate the existence of an association between Parkinson disease and environmental exposures in southern Morocco. The authors highlight the frequency and severity of toxic exposures to heavy metals, particularly manganese.

Method: Our prospective study covered the period between February 2005 and October 2009 , include population with variable activities (miners, workers and residents ) of 2 rural community (Kettara and Imini) located in south of Morocco, as well as patients followed for PD at the Neurology Department of the University Hospital Mohammed VI, Morocco. An epidemiological, clinical and toxicological studies of the blood, was performed on 120 subjects divided into four groups (G1: 30 exposed and sick, G2: 30 non-exposed and not sick, G3: 30 exposed and not sick and G4: 30 non-exposed and sick) in order to demonstrate the relation between Environmental toxicants and Parkinson’s disease in south of Morocco.

Results: The study includes 3 parameters: the neurological examination; a toxicological study in blood as well as a toxicological study of the environment. The results noted on the first site (Imini) show that 5,7% of the population presents a Parkinson’s syndrome; on the level of the 2nd site (Kettara), the percentage is about 4.5%. Biochemical samples showed a high rate of heavy metals on the various biologic samples and the environment. Manganese was the more represented. The majority of patients did not improve the clinical signs under L-dopa.

Conclusion: Until now, no single environmental agent or class of agents has been conclusively demonstrated epidemiologically to increase PD risk. This study will contribute to our understanding of the association between PD and environmental exposures such as heavy metals, pesticides, and solvents.

To cite this abstract in AMA style:

Y. Naji, N. Kissani. Environmental toxicants and Parkinson’s disease in south of Morocco [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/environmental-toxicants-and-parkinsons-disease-in-south-of-morocco/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/environmental-toxicants-and-parkinsons-disease-in-south-of-morocco/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley